Australia markets closed

Encompass Health Corporation (EHC)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
57.12+0.65 (+1.15%)
At close: 01:00PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 5.64B
Enterprise value 8.53B
Trailing P/E 16.32
Forward P/E 16.75
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.06
Price/book (mrq)4.63
Enterprise value/revenue 1.88
Enterprise value/EBITDA 9.78

Trading information

Stock price history

Beta (5Y monthly) 0.96
52-week change 320.55%
S&P500 52-week change 3-13.51%
52-week high 359.36
52-week low 342.19
50-day moving average 351.33
200-day moving average 351.50

Share statistics

Avg vol (3-month) 3739.88k
Avg vol (10-day) 3505.74k
Shares outstanding 599.79M
Implied shares outstanding 6N/A
Float 897.76M
% held by insiders 12.04%
% held by institutions 1100.23%
Shares short (14 Nov 2022) 42.78M
Short ratio (14 Nov 2022) 43.06
Short % of float (14 Nov 2022) 43.63%
Short % of shares outstanding (14 Nov 2022) 42.79%
Shares short (prior month 13 Oct 2022) 43.13M

Dividends & splits

Forward annual dividend rate 40.6
Forward annual dividend yield 41.05%
Trailing annual dividend rate 30.99
Trailing annual dividend yield 31.75%
5-year average dividend yield 41.65
Payout ratio 428.61%
Dividend date 316 Jan 2023
Ex-dividend date 429 Dec 2022
Last split factor 21257:1000
Last split date 330 June 2022

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 5.10%
Operating margin (ttm)13.97%

Management effectiveness

Return on assets (ttm)7.67%
Return on equity (ttm)21.70%

Income statement

Revenue (ttm)5.36B
Revenue per share (ttm)54.06
Quarterly revenue growth (yoy)7.80%
Gross profit (ttm)2.03B
EBITDA 1.02B
Net income avi to common (ttm)346.4M
Diluted EPS (ttm)3.46
Quarterly earnings growth (yoy)-54.60%

Balance sheet

Total cash (mrq)59.8M
Total cash per share (mrq)0.6
Total debt (mrq)2.95B
Total debt/equity (mrq)168.85
Current ratio (mrq)1.21
Book value per share (mrq)12.19

Cash flow statement

Operating cash flow (ttm)657.4M
Levered free cash flow (ttm)92.58M